18/09/2024

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

18/09/2024

Sep 18, 2024, 22:50 | Blog,Insight
Kimryn Rathmell: Tovorafenib has been approved for kids and teens who have low-grade glioma
Kimryn Rathmell shared a post on X: "Recent Childhood Cancer breakthrough: Tovorafenib (Ojemda) has been…
Sep 18, 2024, 22:46 | Blog
Amer Zeidan: The 7th annual NEHEME New England Hematologic Diseases Symposium
Amer Zeidan shared on X: "Outstanding meeting with excellent speakers and very engaged discussion at the…
Sep 18, 2024, 21:59 | Blog
Kimryn Rathmell: Happy National Postdoc Appreciation Week
Kimryn Rathmell shared a post on X: "Happy National Postdoc Appreciation Week! I want to personally…
Sep 18, 2024, 17:57 | Blog
Pat Price: I believe the cancer crisis is our most pressing health emergency at present
Pat Price shared a post on LinkedIn: "I believe the cancer crisis is our most pressing…
Sep 18, 2024, 17:49 | Blog
Atrium Health Levine Cancer Proton and Advanced Radiation Center will soon be the first and only site in the Carolinas to offer proton beam therapy
Atrium Health Foundation shared a post on LinkedIn: "Atrium Health Levine Cancer Proton and Advanced…
Sep 18, 2024, 17:34 | Blog
Suzan DelBene: Celebrating 30 years of the Violence Against Women Act
Suzan DelBene, Co-chair of the Women's High-Tech Coalition, Kidney Caucus, and MedTech Caucus, shared on…
Sep 18, 2024, 16:43 | Blog
The first anniversary of ESMO Ambassadors initiative
ESMO posted on X: "ESMO Ambassadors: We are excited to mark the first anniversary of…
Sep 18, 2024, 16:38 | Insight
Pierre Blanchard: The molecular analysis of the PEACE 1 trial
Pierre Blanchard, Radiation Oncology Clinical section chief at Gustave Roussy Cancer Institute, shared on X: "Dr Pobel…
Sep 18, 2024, 16:34 | Blog
Roupen Odabashian: The ability to measure a marker doesn't equate to clinical benefit
Roupen Odabashian posted on LinkedIn: "The ability to measure a marker doesn't equate to clinical…
Sep 18, 2024, 16:29 | Blog
Francisco J. Esteva: A new era in personalized medicine for high-risk stage 2/3 breast cancer
Francisco J. Esteva, Chief, Division of Hematology and Medical Oncology at Lenox Hill Hospital, shared…
All: 83 Posts: 11 - 20
Special Coverage